Hodgkin Lymphoma survivors treated during adolescence or adulthood are at high risk for cardiovascular diseases throughout their lives.
Hodgkin Lymphoma survivors face a persistently increased risk of cardiovascular disease throughout their lives, necessitating awareness from physicians and patients.
Throughout their lives, HL survivors treated at adolescence or adulthood are at high risk for various cardiovascular diseases. Physicians and patients should be aware of this persistently increased risk.
Nimwegen et al. (2015) studied this question. Hodgkin Lymphoma survivors treated during adolescence or adulthood are at high risk for cardiovascular diseases throughout their lives.